One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Potassium-competitive acid blockers versus proton pump inhibitors: redefining the standards of care in reflux esophagitis.
doi : 10.1097/MEG.0000000000003052
Volume 37(12) pgs. 1309-1410,e1-e7 December 2025
Tegoprazan vs. proton pump inhibitors for erosive esophagitis: a superior alternative or just another option? A systematic review and meta-analysis of randomized controlled trials.
Global prevalence and risk factors of irritable bowel syndrome from 2006 to 2024 using the Rome III and IV criteria: a meta-analysis.
Home-based transcutaneous electrical acupuncture-point stimulation for depressive symptoms in inflammatory bowel disease: a randomized feasibility study.
Accuracy of the American Society for Gastrointestinal Endoscopy, European Society of Gastrointestinal Endoscopy, and Society of American Gastrointestinal and Endoscopic Surgeons criteria in predicting common bile duct microlithiasis.
Polygenic risk of refractory celiac disease type II and its association with autoimmune diseases: a phenome-wide association study in the UK Biobank.
The efficacy and safety of endoscopic submucosal resection in periappendiceal lesions: a systematic review and meta-analysis.
Differential association of platelet indices in NAFLD/NASH: a Mendelian randomized study.
Serum metabolites and gut microbiota mediate the causal link between anxiety and nonalcoholic fatty liver disease: a Mendelian randomization analysis.
Differential effects of sleep duration on cardiovascular risk in metabolic-associated fatty liver disease vs. without metabolic-associated fatty liver disease: evidence from National Health and Nutrition Examination Survey and Mendelian randomization.
Safety and effectiveness of transient ascites drainage in hospitalized patients with large ascites.
Bevacizumab for refractory gastrointestinal angiodysplasia: a case report and literature review.
Infliximab-induced pulmonary interstitial disease in a male patient with ulcerative colitis: a case report and review of literature.
